221 filings
Page 7 of 12
DEFA14A
2i2u5
25 Apr 19
Additional proxy soliciting materials
7:02am
8-K
j8bbyj 5pt7
2 Apr 19
Athenex Announces Appointment of John Koh as a New Board Member
7:05am
8-K
qyvg212za hz
29 Mar 19
Athenex Announces Appointment of Jordan S. Kanfer
4:20pm
CT ORDER
fwsy9sdoqe6oad59
22 Mar 19
Confidential treatment order
12:00am
8-K
pfqp0b
21 Mar 19
Athenex Announces Expansion of Board of Directors
8:46am
8-K
049gwj dfjktjyr
11 Mar 19
Positive Phase III topline results ofKX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD Annual Meeting
7:30am
8-K
awul wz2bb416jqz1
7 Mar 19
Termination of a Material Definitive Agreement
5:14pm
8-K
270z v4n89vv4v79
6 Mar 19
Departure of Directors or Certain Officers
7:51am
8-K
wwrhjc02q9m604llj
4 Mar 19
Regulation FD Disclosure
7:00am
CT ORDER
m5jrm1we6sj 80fj
26 Feb 19
Confidential treatment order
3:08pm
8-K
pt32b9px
3 Jan 19
Chongqing Jingdong Pharmaceutical and Athenex announce a strategic partnership and licensing agreement to develop and commercializeKX2-391 in China
7:00am
CT ORDER
xv55e
20 Dec 18
Confidential treatment order
12:00am
8-K
iyb1khspt4s0
17 Dec 18
Regulation FD Disclosure
7:01am
8-K
fd4ydx8c9pwp49f
4 Dec 18
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
5:17pm
8-K
yppcvzndmvni4iz
14 Nov 18
Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update
7:00am
8-K
2n1qm ejf4
22 Oct 18
Regulation FD Disclosure
7:09am
S-3ASR
4ii aur0c77mnv3w
24 Sep 18
Automatic shelf registration
6:33am